Filter
2996
Filtered Results: 2996
Text search:
World
Health
Organization
WHO,
Regional
Office
for
Europe
Featured
Recommendations
266
New Publications
626
Language
Document type
No document type
1448
Studies & Reports
680
Guidelines
393
Manuals
189
Strategic & Response Plan
117
Fact sheets
52
Training Material
46
Situation Updates
44
Resource Platforms
11
Brochures
8
Infographics
5
Online Courses
2
App
1
Countries / Regions
Global
180
Western and Central Europe
161
Ukraine
102
Eastern Europe
76
Sierra Leone
51
Russia
49
Syria
44
Liberia
39
Nepal
37
Africa
36
Myanmar / Burma
35
Kenya
34
Latin America and the Carribbean
34
Eastern Europe and Central Asia
34
India
34
Ethiopia
33
Zambia
29
Uganda
27
South Africa
26
Ghana
25
South–East Asia Region
24
Nigeria
22
Asia
21
Germany
21
Guinea
19
Tanzania
19
Bangladesh
19
South Sudan
18
West and Central Africa
17
Middle East and North Africa
16
Malawi
15
East and Southern Africa
15
Moldova
15
Namibia
15
Rwanda
14
Tajikistan
13
Senegal
12
Mozambique
12
Congo, Democratic Republic of
12
Pakistan
12
Burkina Faso
11
Afghanistan
11
Philippines
11
Jordan
11
Thailand
10
Zimbabwe
10
North Macedonia
9
Albania
9
Venezuela
9
Lebanon
9
Yemen
9
Indonesia
9
Somalia
9
Lesotho
8
China
8
Kyrgyzstan
8
Cambodia
8
Western Pacific Region
8
Brazil
8
Georgia
8
Central African Republic
8
Eswatini/ Swaziland
8
Haiti
7
Romania
7
Poland
7
Botswana
7
Turkey
6
Cameroon
6
Armenia
6
Sri Lanka
6
Iraq
6
Kazakhstan
5
Iran
5
USA
5
Hungary
5
Vietnam
5
Greece
5
Benin
4
Laos
4
Estonia
4
Belarus
4
Sudan
4
Madagascar
4
Colombia
3
Mexico
3
Serbia
3
Guinea-Bissau
3
Turkmenistan
3
Jamaica
3
Côte d’Ivoire / Ivory Coast
3
Mali
3
Canada
2
Uzbekistan
2
Burundi
2
Peru
2
Morocco
2
Bulgaria
2
Croatia
2
Lithuania
2
Paraguay
2
United Kingdom
2
Portugal
2
Azerbaijan
2
Bosnia and Herzegovina
2
Papua New Guinea
2
Egypt
2
Slovakia
2
Palestine
2
Chad
2
Libya
2
North Korea
1
Gambia
1
Togo
1
Fiji
1
Niger
1
Vanuatu
1
Mongolia
1
Qatar
1
Mauritania
1
Dominican Republic
1
Ireland
1
Saudi Arabia
1
North America
1
Gabon
1
Belgium
1
Mauritius
1
Tunisia
1
Norway
1
Spain
1
Israel
1
Latvia
1
Southern Africa
1
Argentina
1
Angola
1
Bhutan
1
Ecuador
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
689
Key Resources
234
Clinical Guidelines
220
Public Health
187
Women & Child Health
169
Capacity Building
41
Pharmacy & Technologies
27
Toolboxes
Mental Health
287
HIV
278
COVID-19
274
TB
191
Planetary Health
170
Rapid Response
137
Disability
135
Conflict
135
AMR
108
Refugee
98
Global Health Education
91
Caregiver
71
Ebola & Marburg
70
NTDs
61
Pharmacy
56
NCDs
50
Health Financing Toolbox
49
Natural Hazards
37
Zika
29
Specific Hazards
27
Malaria
17
Polio
17
Cholera
10
Social Ethics
9
Typhoon
4
The aim of these Guidelines is to provide a framework for the conservation and sustainable use of plants in medicine. To do this, the Guidelines describe the various tasks that should be carried out to ensure that where medicinal plants are taken from the wild, they are taken on a basis that is sust...
Повышение цены на алкоголь является одной из наиболее эффективных мер политики по сокращению общего потребления алкоголя в стране и, следовательно, по снижению ур...
This technical report presents the epidemiology of human and animal leishmaniases in the EU and its neighbouring countries and concludes that the disease remains widespread and underreported in many countries of southern Europe, northern Africa, and the Middle East and that there is a need to improv...
Constituting the second part of the World Drug Report 2022, the present booklet contains an overview of the global demand for and supply of drugs.
The first chapter of the booklet begins with the latest estimates of the number of people who use drugs, the distribution of those users by type of drug...
The strategic framework gives guidance to public and private health facilities and health workers on compliance with standards relating to IPC practices. To further assist health facilities to implement the IPC strategic framework, this practical implementation manual has been developed in parallel ...
These guidelines have been developed to provide guidance to the Ministry of Health in managing applications for registration of human pharmaceutical products in Rwanda. It was compiled by the Technical Working Group (TWG) on Medicines Evaluation and Registration (MER) of the East African Community M...
Migrants in an irregular situation: access to healthcare in 10 European Union Member States
recommended
This report explores the access to healthcare granted to irregular migrants in 10 EU Member States. It focuses on migrants who are present in an irregular situation, namely those who do not fulfil conditions for entry, stay or residence. Through interviews with a range of different sources including...
Despite some improvements, current levels of air pollution still pose a considerable risk to the environment and to human health in the WHO European Region. One issue of concern is that monitoring of particulate matter is very limited in the countries of eastern Europe, the Caucasus and central Asia...
Blueprint for EECA countries, first edition
МОДЕЛЬ ПРОТИВОТУБЕРКУЛЕЗНОЙ ПОМОЩИ, ОРИЕНТИРОВАННАЯ НА НУЖДЫ ЛЮДЕЙ
Концептуальный проект модели для стран Восточной Европы и Центрально...
This document provides guidance to Member States in the WHO European Region that wish to conduct behavioural insights studies related to COVID-19. Studies can be used to monitor public knowledge, risk perceptions, behaviours and trust with the overall aim to inform national COVID-19 outbreak respons...
an operational guide to support all those responsible for planning and implementing the rollout of COVID-19 vaccine to refugees and migrants at national and local levels, 14 March 2022
The purpose of the review was to assign a cause of death, to ascertain the fac-tors that contributed to the death and to identify any systemic issues that could be addressed to prevent future similar deaths. The perinatal mortality audit process in 2019 provided important insights and evidence-based...
WHO is working closely with our offices in Ukraine and neighbouring countries, as well as partners to rapidly respond to the health emergency triggered by the conflict and to minimize disruptions to the delivery of critical healthcare services.
WHO continues to deliver much-needed support on urge...
Antimicrobial resistance (AMR) is a serious public health concern with economic, social and political implications that are global in scope, and cross all environmental and ethnic boundaries. As a global threat, AMR risks the achievements of modern medicine, and has the po...
This guidance document provides basic broad principles for a spokesperson
of any health authority on how to respond to vocal vaccine deniers.
The suggestions are based on psychological research on persuasion,
on research in public health, communication studies and on WHO risk
communication guide...
Manual for Early Implementation
While there has been real progress in addressing the burden of disease in the WHO African region, the COVID-19 pandemic has highlighted the link between health, economics and security, as the region saw decades of progress threatened, including positive trends in decreasing inequality. In the Africa...
The publication of the Second Edition of the Emergency Drug Guidelines represents the culmination of the efforts of the National Drugs and Therapeutics Committee (NDTC) to publish clinical drug guidelines for common diseases seen in Fiji. These guidelines are targeted for health care professionals w...
Руководство по осуществлению mhGAP
recommended
The WHO Mental Health Gap Action Programme (mhGAP) aims at scaling up mental health services in non-specialized health settings to achieve universal health coverage. The mhGAP operations manual is an integral component of the mhGAP package and supports district health managers and others responsible...
Updated recommendations on treatment of adolescents and children with chronic HCV infection
recommended
The new treatment recommendations that extend the 2018 treat all recommendation for adults with chronic HCV infection to include adolescents and children down to 3 years, and to align the existing recommended pangenotypic direct-acting antiviral (DAA) regimens (SOF/DCV, SOF/VEL and G/P) for adults, ...
